search
Back to results

Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction

Primary Purpose

Contrast Induced Nephropathy

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Hydration
Acetylcysteine
Sodium bicarbonate
Combined Acetylcystein and Sodium Bicarbonate
Sponsored by
Odense University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Contrast Induced Nephropathy focused on measuring CIN STEMI

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • STEMI patients treated with primary PCI

Exclusion Criteria:

  • Cardiogenic shock

Sites / Locations

  • Odense University Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

Standard treatment

Combined Acetylcystein and Sodium Bicarbonat

Sodium Bicarbonate

Acetylcystein for 2 days

Arm Description

Hydration

Standard treatment + acetylcystein for 2 days

Outcomes

Primary Outcome Measures

Prevention of contrast induced nephropathy in STEMI patients treated with primary PCI
Rise in creatinine >25% from baseline to day 3

Secondary Outcome Measures

Prevention of contrast induced nephropathy in STEMI patients treated with primary PCI
Rise in creatinine >25% from baseline to day 30

Full Information

First Posted
July 9, 2010
Last Updated
March 21, 2013
Sponsor
Odense University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01160627
Brief Title
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
Official Title
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
Study Type
Interventional

2. Study Status

Record Verification Date
March 2013
Overall Recruitment Status
Completed
Study Start Date
April 2010 (undefined)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
March 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Odense University Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
OBJECTIVE: To evaluate the efficacy of prevention of contrast induced nephropathy in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. DESIGN: Prospective study. SETTING: Three-center study Acute kidney injury was defined as a rise in creatinine >25% from baseline Serum creatinine will be measured at baseline and each day for the following 3 days and at 30 days. Patients will be randomised to: Standard treatment Standard treatment + acetylcystein for 2 days Standard treatment + Sodium bicarbonate 500 ml / followed by 100 ml/h for 5 hours Standard treatment + acetylcystein for 2 days + Sodium bicarbonate 500 ml / followed by 100 ml/h for 5 hours

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Contrast Induced Nephropathy
Keywords
CIN STEMI

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
720 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard treatment
Arm Type
Active Comparator
Arm Description
Hydration
Arm Title
Combined Acetylcystein and Sodium Bicarbonat
Arm Type
Active Comparator
Arm Title
Sodium Bicarbonate
Arm Type
Active Comparator
Arm Title
Acetylcystein for 2 days
Arm Type
Active Comparator
Arm Description
Standard treatment + acetylcystein for 2 days
Intervention Type
Other
Intervention Name(s)
Hydration
Intervention Description
Saline hydration
Intervention Type
Drug
Intervention Name(s)
Acetylcysteine
Intervention Description
Acetylcystein tablets for 2 days
Intervention Type
Drug
Intervention Name(s)
Sodium bicarbonate
Intervention Description
Sodium bicarbonate 500 ml followed by 100 ml/hour for 5 hours
Intervention Type
Drug
Intervention Name(s)
Combined Acetylcystein and Sodium Bicarbonate
Intervention Description
Sodium bicarbonate 500 ml followed by 100 ml/hour for 5 hours combined with acetylcystein tablets for 2 days
Primary Outcome Measure Information:
Title
Prevention of contrast induced nephropathy in STEMI patients treated with primary PCI
Description
Rise in creatinine >25% from baseline to day 3
Time Frame
from baseline to day 3
Secondary Outcome Measure Information:
Title
Prevention of contrast induced nephropathy in STEMI patients treated with primary PCI
Description
Rise in creatinine >25% from baseline to day 30
Time Frame
from baseline to day 30

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: STEMI patients treated with primary PCI Exclusion Criteria: Cardiogenic shock
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Per Thayssen, MD DMSci
Organizational Affiliation
Odense University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Odense University Hospital
City
Odense
ZIP/Postal Code
5000
Country
Denmark

12. IPD Sharing Statement

Citations:
PubMed Identifier
24714489
Citation
Thayssen P, Lassen JF, Jensen SE, Hansen KN, Hansen HS, Christiansen EH, Junker A, Ravkilde J, Thuesen L, Veien KT, Jensen LO. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial. Circ Cardiovasc Interv. 2014 Apr;7(2):216-24. doi: 10.1161/CIRCINTERVENTIONS.113.000653. Epub 2014 Apr 8.
Results Reference
derived

Learn more about this trial

Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction

We'll reach out to this number within 24 hrs